Lanzhou Foci Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000019W4
CNY
9.07
0.06 (0.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
966.13
1,149.77
1,027.83
802.83
654.23
615.67
535.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
966.13
1,149.77
1,027.83
802.83
654.23
615.67
535.92
Raw Material Cost
700.41
821.30
753.19
603.50
511.76
467.94
377.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
153.24
188.51
187.24
156.30
122.69
121.74
110.21
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.89
1.47
2.04
1.05
1.39
1.17
0.69
Selling and Distribution Expenses
202.05
236.76
191.89
137.68
116.86
145.98
94.61
Other Expenses
-12.81
-16.26
-16.78
-14.04
-11.06
-10.43
-9.33
Total Expenditure (Excl Depreciation)
928.47
1,085.42
966.58
758.18
642.06
632.52
489.44
Operating Profit (PBDIT) excl Other Income
37.7
64.4
61.2
44.699999999999996
12.2
-16.8
46.5
Other Income
38.42
24.39
75.84
69.69
123.80
104.49
42.61
Operating Profit (PBDIT)
133.94
146.56
190.55
162.39
189.06
141.51
123.24
Interest
0.89
1.47
2.04
1.05
1.39
1.17
0.69
Exceptional Items
0.40
-0.00
-0.20
-0.44
0.23
-0.41
0.00
Gross Profit (PBDT)
265.72
328.48
274.64
199.33
142.48
147.73
158.70
Depreciation
55.87
58.88
53.59
48.14
52.76
53.46
34.50
Profit Before Tax
77.58
86.21
134.71
112.76
135.15
86.47
88.05
Tax
7.47
13.52
21.37
17.30
22.81
8.79
13.77
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
60.07
67.19
108.65
93.26
108.02
74.85
74.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
60.07
67.19
108.65
93.26
108.02
74.85
74.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.60
0.93
0.69
0.26
-0.31
-0.18
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
61.67
68.12
109.35
93.52
107.71
74.67
74.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,789.89
1,745.37
1,719.05
1,614.58
1,582.09
1,510.00
1,441.40
Earnings per share (EPS)
0.12
0.13
0.21
0.18
0.21
0.15
0.15
Diluted Earnings per share
0.12
0.13
0.21
0.18
0.21
0.15
0.15
Operating Profit Margin (Excl OI)
4.1%
5.5%
5.95%
5.55%
1.91%
-2.67%
8.61%
Gross Profit Margin
13.81%
12.62%
18.32%
20.04%
28.72%
22.73%
22.87%
PAT Margin
6.22%
5.84%
10.57%
11.62%
16.51%
12.16%
13.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -15.98% vs 11.87% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -9.40% vs -37.69% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -21.85% vs 6.54% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -40.00% vs -25.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Lanzhou Foci Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
966.13
0
966.13
Other Operating Income
0.00
0.00
0.00
Total Operating income
966.13
0
966.13
Raw Material Cost
700.41
0
700.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
153.24
0
153.24
Power Cost
0
0
0.00
Manufacturing Expenses
0.89
0
0.89
Selling and Distribution Expenses
202.05
0
202.05
Other Expenses
-12.81
0.00
-12.81
Total Expenditure (Excl Depreciation)
928.47
0
928.47
Operating Profit (PBDIT) excl Other Income
37.66
0.00
37.66
Other Income
38.42
0
38.42
Operating Profit (PBDIT)
133.94
0
133.94
Interest
0.89
0
0.89
Exceptional Items
0.40
0
0.40
Gross Profit (PBDT)
265.72
0
265.72
Depreciation
55.87
0
55.87
Profit Before Tax
77.58
0
77.58
Tax
7.47
0
7.47
Provisions and contingencies
0
0
0.00
Profit After Tax
60.07
0
60.07
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
60.07
0
60.07
Share in Profit of Associates
0
0
0.00
Minority Interest
1.60
0
1.60
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.67
0
61.67
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,789.89
0
1,789.89
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
4.10%
0%
0.00
4.10%
Gross Profit Margin
13.81%
0%
0.00
13.81%
PAT Margin
6.22%
0%
0.00
6.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 96.61 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -15.98% vs 11.87% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 6.17 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -9.40% vs -37.69% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.55 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -21.85% vs 6.54% in Dec 2023

Annual - Interest
Interest 0.09 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -40.00% vs -25.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.10%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023